
Granistop 1mg Tablet MD
Marketer
B.J.Healthcare
Salt Composition
Granisetron (1mg)
Overview Granistop 1mg Tablet MD
Ondansetron 1mg tablets are prescribed to alleviate nausea and vomiting stemming from surgery, chemotherapy, or radiation therapy. This medication is not effective against other cancer treatment side effects, nor is it useful for motion sickness. Always adhere to your physician's prescribed dosage and schedule; consistent timing is recommended. Discontinue use only under medical supervision. If vomiting occurs within an hour of ingestion, repeat the dose and avoid large meals for the remainder of the day. Common side effects include headache, constipation, diarrhea, fatigue, dizziness, and drowsiness. Refrain from driving or operating machinery until the medication's effects are known. These side effects typically subside upon cessation of treatment; however, persistent or bothersome symptoms warrant medical consultation. Prior to commencing treatment, inform your doctor of any existing heart or liver conditions, gastrointestinal obstructions, or concurrent medications, particularly those for epilepsy, cardiac issues, cancer, or depression, as interactions are possible. Pregnant or breastfeeding individuals should consult their healthcare provider.
Uses of Granistop 1mg Tablet MD
Chemotherapy-induced emesis.
Major Benefits of Granistop 1mg Tablet MD:
Administer this medication according to your physician's prescribed dosage and schedule. Avoid handling the tablets with damp hands. Place the tablet in your mouth, but refrain from swallowing immediately. Granistop 1mg Tablet MD can be ingested with or without food; however, consistent timing is recommended.
Common Side effects of Granistop 1mg Tablet MD:
- Weakness
- Headache
- Constipation
- Diarrhea
- Insomnia (difficulty in sleeping)
How to use Granistop 1mg Tablet MD:
Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Avoid contact with the tablets using damp hands. Place the tablet in your mouth, but refrain from swallowing immediately. Granistop 1mg Tablet MD can be ingested with or without food; however, consistent daily timing is recommended.
How Granistop 1mg Tablet MD works:
Medically prescribed Granistop 1mg tablets counteract nausea and vomiting. This antiemetic achieves its effect by inhibiting serotonin, a neurotransmitter in the brain known to trigger these symptoms, particularly during or following cancer therapy (chemotherapy) and surgical procedures.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Granistop 1mg Tablet MD may pose unknown risks. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The use of Granistop 1mg Tablet MD during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The use of Granistop 1mg Tablet MD while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Granistop 1mg Tablet MD.
KidneySAFE IF PRESCRIBED
Use of Granistop 1mg Tablet MD in patients with kidney impairment appears safe, based on currently available, albeit limited, evidence. Dosage modification may not be necessary; however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Granistop 1mg Tablet MD in patients with liver impairment is likely safe. Preliminary evidence indicates dose modification may be unnecessary. However, physician consultation is recommended.
What if you forget to take Granistop 1mg Tablet MD :
Should you forget a Granistop 1mg Tablet MD dose, ingest it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Granistop 1mg Tablet MD
| Label | Value |
|---|---|
| Chemical Type | Indazole-based compound |
| Developing Habits | No. |
| Type of Treatment | Gastrointestinal system |
| Actions | 5-HT3 receptor blockers |
